On 25 August 2026, a field visit was conducted to DHQ Hospital Mardan and the Frontier Primary Health Care (FPHC) Office to support and strengthen the implementation of pharmacovigilance activities. During the visit, the Risk Awareness and Communication Plan, developed as part of CMU’s pharmacovigilance activities, was piloted at DHQ Hospital Mardan.
The visit also focused on strengthening the capacity of healthcare professionals in Adverse Drug Reaction (ADR) reporting, expanding VigiFlow-based pharmacovigilance reporting, and supporting active ADR inquiry and patient follow-up at the pilot site.
These activities contribute to strengthening Pakistan’s national pharmacovigilance system, particularly within the Malaria Control Program, and represent CMU’s contribution towards achieving WHO Global Benchmarking Tool (GBT) Level 3 for pharmacovigilance.
